This site uses cookies to ensure the best viewing experience for our readers.
Read more about it Got It

Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq

0 Comment Add Comment Add Comment

Post comment Cancel
Got it! We'll post your comment